167. Duration of Methicillin-Resistant Staphylococcus aureus (MRSA) Nares PCR Positivity while Receiving Highly Active Anti-Staphylococcal Drugs
Maximillian S Wu,Wesley D Kufel,Scott W Riddell,Jeff Steele,Elizabeth Asiago-Reddy
DOI: https://doi.org/10.1093/ofid/ofad500.240
2023-11-27
Open Forum Infectious Diseases
Abstract:Abstract Background A growing body of evidence has demonstrated a close association between nasal colonization with methicillin-resistant Staphylococcus aureus (MRSA) and its invasive presence systemically. Thus, several hospitals have implemented MRSA nares PCR screening for all patients initiating treatment active against MRSA for various infections to help de-escalate an anti-MRSA antibiotic in the event of a negative result. However, little is known about the effects of anti-MRSA systemic agents on MRSA nasal colonization, potentially affecting the use of MRSA PCR as an effective screening tool if not conducted immediately upon hospital admission. Methods Adult Upstate University Hospital patients ≥ 18 years of age with an initial positive MRSA nares PCR result were considered for inclusion, starting from September 2022. Eligible patients were individuals who had a positive MRSA nares PCR performed within 36 hours of their initial dose of a systemic anti-MRSA antibiotic. Positive MRSA nares cultures were also considered if PCRs were initially indeterminate. Anti-MRSA antibiotics included vancomycin, daptomycin, linezolid, ceftaroline, and clindamycin. Patients who were received these agents for a duration of 48-96 hours were consented for their participation. If consented, a follow-up MRSA nares swab and PCR were collected at a goal timepoint of 72 hours post initiation of anti-MRSA antibiotics (sample collection ranged from 48-96 hours post initiation). MRSA colonization was reassessed with a repeat nares PCR and reflex to culture for indeterminate results if applicable. Results As of April 21st, 2023, 61 follow-up MRSA nares samples were collected from eligible participants. Follow-up samples were collected an average of 66.51 hours after their first dose of anti-MRSA drugs (IQR = 11.47). Of these follow-up samples, 56/61 (91.80%) resulted as a positive MRSA nares PCR or culture result. Conclusion Our interim results demonstrated that MRSA colonization in the nares via PCR generally persists even after 48-96 hours of continuous systemic administration of anti-MRSA antibiotics. These findings suggest that MRSA nares swabs can still be used after anti-MRSA antibiotic administration, increasing its utility as a screening tool. Disclosures Wesley D. Kufel, Pharm.D., BCPS, BCIDP, AAHIVP, Merck & Co.: Grant/Research Support Elizabeth Asiago-Reddy, MD, Glaxo-Smith-Kline: Grant/Research Support|Pfizer: Grant/Research Support
immunology,infectious diseases,microbiology